miR‑144‑3p Regulates the Resistance of Lung Cancer to Cisplatin by Targeting Nrf2

Oncology Reports - Greece
doi 10.3892/or.2018.6772
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-17-3P Regulates the Proliferation and Survival of Colon Cancer Cells by Targeting Par4

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

miR-193a-3p Regulates the Multi-Drug Resistance of Bladder Cancer by Targeting the LOXL4 Gene and the Oxidative Stress Pathway

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2

Oncology Reports
MedicineCancer ResearchOncology
2018English

The miR-1204 Regulates Apoptosis in Lung Cancer Cells by Targeting DEK

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2019English

circRNA_001275 Upregulates Wnt7a Expression by Competitively Sponging miR‑370‑3p to Promote Cisplatin Resistance in Esophageal Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

P077 miR-338-3p Promotes the Resistance of Non-Small Cell Lung Cancers to EGFR-TKI by Targeting PTPN12

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

LINC00528 Regulates Myocardial Infarction by Targeting the miR-143-3p/COX-2 Axis

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

miR-142-3p Inhibits Cancer Cell Proliferation by Targeting CDC25C

Cell Proliferation
MedicineCell Biology
2016English

Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy